Moderna begins Phase 1 trial of Bundibugyo ebolavirus vaccine

August 4, 2026 11:01 AM

Moderna (NASDAQ: MRNA) has dosed the first participants in a Phase 1 clinical trial of mRNA-1469, an investigational mRNA vaccine ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found